Agilysys director exercises 973 RSUs into shares
AGILYSYS INC director John Mutch exercised equity awards rather than trading shares in the market.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AGILYSYS INC director John Mutch exercised equity awards rather than trading shares in the market. On May 22, 2026, he converted 973 Restricted Stock Units into 973 shares of Common Stock at an exercise price of $79.84 per share. Following the transaction, he directly holds 32,377 shares of Common Stock. The filing shows no open-market purchases or sales, only a compensation-related derivative exercise, and no remaining derivative positions are listed after this event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 973 | $0.00 | $0.00 |
| Exercise | Common Stock | 973 | $79.84 | $78K |
Key Figures
Key Terms
Restricted Stock Units financial
derivative security financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did AGYS director John Mutch report in this Form 4 filing?
Were there any open-market buys or sells in John Mutch’s latest AGYS Form 4?
Does John Mutch have remaining derivative positions in Agilysys after this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.